Dyadic International (NASDAQ:DYAI) Stock Passes Above 50 Day Moving Average – Here’s What Happened

Dyadic International, Inc. (NASDAQ:DYAI) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.56 and traded as high as $1.99. Dyadic International shares last traded at $1.73, with a volume of 171,662 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 price target on shares of Dyadic International in a research note on Thursday, November 14th.

Dyadic International Stock Down 4.3 %

The firm has a market capitalization of $48.82 million, a P/E ratio of -7.17 and a beta of 0.89. The stock has a fifty day moving average price of $1.57 and a two-hundred day moving average price of $1.39. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15.

Dyadic International (NASDAQ:DYAI) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.06. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. The firm had revenue of $1.96 million during the quarter, compared to the consensus estimate of $1.05 million. During the same period in the prior year, the business earned ($0.06) EPS. Research analysts forecast that Dyadic International, Inc. will post -0.18 EPS for the current year.

Institutional Investors Weigh In On Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Chapin Davis Inc. boosted its holdings in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 868,301 shares of the biotechnology company’s stock after buying an additional 21,000 shares during the period. Chapin Davis Inc. owned approximately 2.97% of Dyadic International worth $903,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 27.95% of the company’s stock.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.